CIBC Private Wealth Group LLC Raises Stake in CME Group Inc. (NASDAQ:CME)

CIBC Private Wealth Group LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 62.0% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,113,142 shares of the financial services provider’s stock after purchasing an additional 426,076 shares during the period. CIBC Private Wealth Group LLC owned approximately 0.31% of CME Group worth $227,335,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Truist Financial Corp raised its stake in shares of CME Group by 8.8% during the 4th quarter. Truist Financial Corp now owns 185,638 shares of the financial services provider’s stock worth $33,795,000 after buying an additional 15,060 shares during the last quarter. Maryland State Retirement & Pension System acquired a new position in shares of CME Group during the 4th quarter worth $1,031,000. RMB Capital Management LLC raised its stake in shares of CME Group by 0.7% during the 1st quarter. RMB Capital Management LLC now owns 89,913 shares of the financial services provider’s stock worth $18,363,000 after buying an additional 625 shares during the last quarter. Waverton Investment Management Ltd raised its stake in shares of CME Group by 42.8% during the 1st quarter. Waverton Investment Management Ltd now owns 609,931 shares of the financial services provider’s stock worth $124,566,000 after buying an additional 182,683 shares during the last quarter. Finally, Creative Planning raised its stake in shares of CME Group by 5.9% during the 1st quarter. Creative Planning now owns 23,122 shares of the financial services provider’s stock worth $4,722,000 after buying an additional 1,288 shares during the last quarter. Institutional investors own 85.92% of the company’s stock.

In other CME Group news, insider Julie Winkler sold 3,500 shares of the company’s stock in a transaction that occurred on Thursday, May 27th. The stock was sold at an average price of $217.00, for a total value of $759,500.00. Following the transaction, the insider now directly owns 25,400 shares of the company’s stock, valued at approximately $5,511,800. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Elizabeth A. Cook sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 9th. The shares were sold at an average price of $216.15, for a total value of $432,300.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,500 shares of company stock valued at $8,585,610. 0.30% of the stock is owned by company insiders.

CME has been the subject of several research reports. Morgan Stanley started coverage on CME Group in a research note on Friday. They set an “equal weight” rating and a $228.00 price target for the company. Rosenblatt Securities reissued a “sell” rating on shares of CME Group in a research note on Wednesday, March 10th. Wells Fargo & Company raised shares of CME Group from an “equal weight” rating to an “overweight” rating and set a $230.00 target price for the company in a research note on Thursday, February 25th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell cut their target price on shares of CME Group from $240.00 to $235.00 and set a “buy” rating for the company in a research note on Monday, April 26th. Finally, Argus reissued a “hold” rating on shares of CME Group in a research note on Thursday, May 6th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $200.69.

NASDAQ CME traded up $0.79 on Friday, reaching $213.66. The company had a trading volume of 9,620 shares, compared to its average volume of 1,577,850. The firm has a market capitalization of $76.72 billion, a price-to-earnings ratio of 39.94, a PEG ratio of 6.64 and a beta of 0.44. CME Group Inc. has a 1 year low of $146.89 and a 1 year high of $221.82. The firm’s 50-day moving average is $210.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 28th. The financial services provider reported $1.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.04. The firm had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.22 billion. CME Group had a return on equity of 8.30% and a net margin of 41.46%. CME Group’s quarterly revenue was down 17.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.33 EPS. As a group, analysts forecast that CME Group Inc. will post 6.76 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 25th. Shareholders of record on Thursday, June 10th will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date is Wednesday, June 9th. CME Group’s dividend payout ratio is presently 53.57%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Further Reading: Special Dividends

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.